Why pre-screen nanomedicine engineers before the technical panel
The gap in this field is between cell culture and a living system. Particles that target beautifully in a dish get cleared by the liver, aggregate in serum or provoke an immune response, and most published work never crosses that boundary. Engineers worth hiring have taken something into a model and watched it behave differently. A short screen asks what happened in vivo.
What actually matters when screening Nanomedicine Engineer candidates
- 01
Theoretical command
Probe command of colloidal stability, PEGylation and opsonisation, EPR effect limits, and biodistribution kinetics; ask them to defend a carrier choice (LNP versus polymeric versus liposomal) for a given payload.
- 02
From theory to hardware or code
Ask what they physically made: microfluidic mixing runs, encapsulation efficiency figures, DLS and cryo-TEM characterisation, in vivo or organoid studies, and any transfer into GLP or GMP batches.
- 03
Research judgement
Test how they chose which formulation variables to screen, killed unpromising constructs, and handled the in vitro to in vivo translation gap under limited animal study budgets.
- 04
Explaining it to non-specialists
Assess how they brief toxicologists, regulatory affairs, and clinicians: CMC documentation, IND-enabling package inputs, and explaining nanoparticle risk without retreating into surface chemistry jargon.
Pre-screening questions to ask Nanomedicine Engineer candidates
12 questions grouped by what they test. Ask the same set in every screen and score answers on a consistent scale, or send them as an async video screen and compare answers side by side.
Beyond the dish
3 questions01Can you describe projects where you applied nanotechnology to a medical problem?
Listen forWork that progressed into animal models or further, with results described including the limits.
Work confined to cell culture, or results reported without any in vivo evaluation.
02What are the main milestones you have achieved in this field?
Listen forConcrete achievements with their own contribution stated, verified by publication or product progress.
Milestones described at team level, or achievements that cannot be evidenced.
03Do you hold patents or have you published in this field?
Listen forPublications or patents they can explain in depth, with their specific contribution clear.
Author lists cited without being able to explain the methods used.
Characterised properly
4 questions04Can you discuss your process for synthesising nanoparticles for therapeutic use?
Listen forSynthesis controlled for size and surface chemistry, with batch reproducibility actually measured.
Batch variation not quantified, or synthesis described without characterisation of the output.
05Can you describe your experience with materials and their behaviour at this scale?
Listen forSurface effects and protein interaction understood, with behaviour in biological media considered.
Properties assumed from bulk material, or protein corona formation not considered.
06What do you know about drug delivery at the nanoscale?
Listen forRealistic view of targeting efficiency, with clearance and biodistribution treated as the main obstacles.
Targeting described as solved, or delivery efficiency assumed rather than measured.
07Do you have experience with design and simulation tools in this field?
Listen forModelling used to guide design, with predictions checked against experimental results afterwards.
Simulation results reported without validation, or models used to replace experiments.
Safety shaped it
3 questions08How do you ensure the safety and effectiveness of nanoscale devices?
Listen forToxicity, clearance and accumulation assessed as core requirements rather than final checks.
Safety testing deferred, or long-term accumulation in organs not considered.
09How familiar are you with the regulatory guidance for this area?
Listen forApplicable requirements known in detail, with characterisation designed to meet the evidence expected.
Regulation treated as a later problem, or the classification of the product unknown.
10What steps do you take to ensure quality control in this work?
Listen forSpecifications defined per batch, with material rejected when it falls outside the range.
Quality assessed retrospectively, or out-of-specification batches used anyway.
Honest about failure
2 questions11Have you worked on a project where the technology did not meet expectations?
Listen forAn honest failure with the mechanism understood, and the decision to stop described plainly.
No failures described, or projects continued long after the evidence turned against them.
12Do you have experience working with clinicians on device development?
Listen forClinical input shaping requirements early, with the practical use of the product understood.
Clinical engagement only at trial stage, or clinical need assumed from literature.
How to score responses
Score every candidate on the same four criteria immediately after the screen. At this stage you are shortlisting for panel interviews, not making the final call.
Theoretical command
35%5Explains zeta potential, PDI and endosomal escape mechanistically, and names conditions where their preferred carrier fails or clears too fast.
From theory to hardware or code
30%5Cites specific formulations with measured EE percentages, particle size distributions, batch sizes, and evidence the material moved beyond bench scale.
Research judgement
20%5Describes a DoE or screening cascade with clear stop criteria, and names a candidate they abandoned plus the data that justified it.
Explaining it to non-specialists
15%5Translates characterisation data into safety and manufacturability implications that a regulatory reviewer or investor can act on directly.
Particles that target beautifully in a dish get cleared by the liver. A one-way video screen asks what happened next.
Try it on HirevireScreening FAQ
Process basics
How long should a pre-screening round for this role take?
Fifteen minutes across eight to ten questions, answered async. Enough to establish work that progressed, test their synthesis and characterisation rigour, and check safety and regulation.
What mix of skills should I expect?
Materials chemistry with biological understanding. Someone strong only in synthesis will make elegant particles that fail the moment they meet serum or an immune system.
Evaluating answers
What is the strongest signal when screening this role?
What happened when the work moved into a living system. Engineers with real experience describe clearance, aggregation or immune response. Anyone whose results held perfectly stayed in culture.
How do I judge their characterisation?
Ask how batch consistency is assessed. Real answers cover size distribution, surface chemistry and stability over time. Anyone reporting a single measurement cannot show reproducibility.
Go deeper on this role
Sanat has been hiring since 2012 and watching the recruitment industry change up close ever since, and turned that screening process into Hirevire's video screening platform. LinkedIn
